#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small intestine neuroendocrine tumour Philadelphia positive chronic myeloid leukaemia Hyperinsulinism Hereditary motor and sensory neuropathy Precursor T-lymphoblastic lymphoma/leukaemia recurrent Neuropathy peripheral Fontan procedure Adrenoleukodystrophy Fatty acid oxidation disorder Ureteric cancer Hyperoxaluria Leukoencephalopathy Eosinophilic granulomatosis with polyangiitis Antisynthetase syndrome Non-Hodgkin's lymphoma refractory More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Basic Information Tuberous sclerosis complex – Diagnostics Crigler-Najjar syndrome – Diagnostics Medulloblastoma – Life with Disease Adrenogenital syndrome – Life with Disease Niemann-Pick disease – Treatment Idiopathic pulmonary fibrosis Waldenstrom’s macroglobulinaemia recurrent Hairy cell leukaemia recurrent – Treatment Medulloblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flortaucipir (18F) MORPHINE Deutivacaftor Valiltramiprosate Omp64 ASP3082 Gemcitabine Ucp2 Odevixibat Neratinib Paltusotine Teriparatide ALENDRONATE SODIUM TRIHYDRATE Moxifloxacin Hydrochloride Glpg3667 Fumarate Glucocorticoids Fludarabine Phosphate Ph. Eur. Cocarboxylase Tetrahydrate INSULIN DETEMIR Bi 765845 More therapies…

    Learn about Your Condition

    Becker's muscular dystrophy Herpes zoster Invasive breast carcinoma Vascular malformation Ovarian cancer stage III Wolfram syndrome Candida infection Myocardial ischaemia Anogenital dysplasia Metastases to meninges Neck pain Cartilage injury Menopausal symptoms Benign prostatic hyperplasia Mucosal inflammation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2af Bplvshuvj Dx Sfntis Mbyjsxuoapl Ba 1jww Mchkjgaygd 1jgfrj Fltcvz

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Anitocabtagene Autoleucel
    • Bortezomib
    • Carfilzomib
    Austria Belgium Czechia France Germany Italy +3

  • Study on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Cabozantinib
    • Lenvatinib
    France

  • Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tucatinib
    • Trastuzumab Emtansine
    Belgium Denmark France Germany Italy The Netherlands +2

  • Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Acute graft versus host disease in intestine
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Austria Belgium France Germany Italy Spain

  • Study on the Effects of Methylprednisolone and Isavuconazonium Sulfate in Immunocompromised Patients with Acute Respiratory Failure of Unknown Cause

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Respiratory failure
    Investigated Drugs:
    • Isavuconazonium Sulfate
    • Methylprednisolone
    France

  • Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    France Germany Italy Spain

  • Study on Treosulfan, Fludarabine Phosphate, and Thiotepa for Patients with Myelofibrosis Undergoing Haplo-identical Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Treosulfan
    • Fludarabine Phosphate
    • Thiotepa
    France

  • Study on Reducing Chemotherapy for Patients with Low-Risk Localized Gastroesophageal Cancer Using Docetaxel, Oxaliplatin, Calcium Folinate, and Fluorouracil

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Calcium Folinate
    • Docetaxel
    • Fluorouracil
    France

  • Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Neuroendocrine carcinoma of the skin
    • Head and neck cancer
    Investigated Drugs:
    • Dostarlimab
    • Atezolizumab
    • Avelumab
    France

  • Study of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • High-grade B-cell lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Cyclophosphamide Monohydrate
    • Cytarabine
    Austria France Germany Italy Spain
Previous Page
1 … 24 25 26 27 28 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!